FCMV

Foresite Capital Management V Portfolio holdings

AUM $80.7M
This Quarter Return
-22.04%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
10 Year Return
AUM
$143M
AUM Growth
+$143M
Cap. Flow
-$19.2M
Cap. Flow %
-13.43%
Top 10 Hldgs %
95.87%
Holding
17
New
Increased
2
Reduced
2
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$28.9M 20.16% 9,400,515
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$18.4M 12.89% 3,335,346 +122,614 +4% +$678K
ACRS icon
3
Aclaris Therapeutics
ACRS
$209M
$17.6M 12.27% 1,258,243
SLGC
4
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$15.9M 11.1% 3,516,472 -210,000 -6% -$949K
HIMS icon
5
Hims & Hers Health
HIMS
$9.57B
$15M 10.51% 3,319,786 +612,864 +23% +$2.78M
CMPX icon
6
Compass Therapeutics
CMPX
$483M
$11.7M 8.15% 4,400,000
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$11M 7.71% 875,001
ACET icon
8
Adicet Bio
ACET
$59.9M
$9.93M 6.94% 680,000
IVVD icon
9
Invivyd
IVVD
$204M
$4.7M 3.28% 1,431,826
IRON icon
10
Disc Medicine
IRON
$2.07B
$4.12M 2.87% 2,435,125
QSI icon
11
Quantum-Si Incorporated
QSI
$227M
$2.15M 1.5% 924,379 -1,417,682 -61% -$3.29M
ENTA icon
12
Enanta Pharmaceuticals
ENTA
$180M
$2M 1.4% 42,250
ME
13
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$1.01M 0.7% 406,913
PHVS icon
14
Pharvaris
PHVS
$1.39B
$755K 0.53% 34,142
CGEM icon
15
Cullinan Oncology
CGEM
$445M
-992,507 Closed -$10.4M
HLTH
16
DELISTED
Cue Health Inc. Common Stock
HLTH
-490,546 Closed -$3.16M
RACB
17
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
-500,000 Closed -$4.88M